Stock 4552 JCR PHARMACEUTICALS CO., LTD.
Add to a list
To use this feature you must be a member
Log inSign up

News JCR Pharmaceuticals Co., Ltd.

Equities

4552

JP3701000006

Delayed Japan Exchange
Other stock markets
 02:00:00 2024-04-23 am EDT 		5-day change 1st Jan Change
808 JPY -0.37% Intraday chart for JCR Pharmaceuticals Co., Ltd. -2.06% -31.06%
Mar. 21 US Fed Rate Outlook Catapults Japanese Shares to Fresh 52-Week Peak MT
Mar. 21 JCR Pharmaceuticals Achieves Neurodegenerative Treatment Research Milestone With Alexion MT

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Final dividend
FA
US Fed Rate Outlook Catapults Japanese Shares to Fresh 52-Week Peak
MT
JCR Pharmaceuticals Achieves Neurodegenerative Treatment Research Milestone With Alexion
MT
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo Technology for Neurodegenerative Disease in Research Collaboration with Alexion
AQ
JCR Pharmaceuticals Announces Achievement of Milestone Using J-Brain Cargo® Technology for Neurodegenerative Disease in Research Collaboration with Alexion
BU
JCR Pharmaceuticals Co., Ltd. Announces Achievement of Milestone Using J-Brain Cargo Technology for Neurodegenerative Disease in Research Collaboration with Alexion
CI
JCR Pharmaceuticals Co., Ltd.(TSE:4552) dropped from FTSE All-World Index
CI
Mycenax Biotech Inc. announced that it expects to receive funding from Center Laboratories, Inc., JCR Pharmaceuticals Co., Ltd., Taiwan BioVenture Company, Jason Technologies Ltd
CI
JCR Pharmaceuticals Celebrates Rare Disease Day 2024 and Highlights Its Commitment to the Rare Disease Community
BU
JCR Pharmaceuticals Co., Ltd. Announces Organizational and Personnel Changes
CI
JCR Pharmaceuticals Research Presentations at WORLDSymposium 2024 Showcase JR-141 and Other Investigational Treatments for Lysosomal Storage Disorders
AQ
JCR Pharmaceuticals’ Research Presentations at WORLDSymposium™ 2024 Showcase JR-141 (Pabinafusp Alfa) and Other Investigational Treatments for Lysosomal Storage Disorders
BU
JCR Pharmaceuticals Co., Ltd. Presents Clinical Data on J-Brain Cargo®? to Deliver Medicines Across the Blood-Brain Barrier
CI
JCR Pharmaceuticals Co., Ltd. Provides Dividend Guidance for the Fiscal Year Ending March 31, 2024
CI
JCR Pharmaceuticals to Present at the 20th Annual WORLDSymposium™ 2024
BU
JCR Pharmaceuticals and Takeda Pharmaceuticals Announce Discontinuation of Gene Therapy Collaboration
BU
JCR Announces Research Collaboration, Option and License Agreement with Alexion on Discovery of Oligonucleotide Therapeutics Using J-Brain Cargo® Technology
BU
Asia Markets Remain Mixed as Investors Step Back Following Rally
MT
Japanese Shares Slip Back into Red as Wall Street Ends Winning Streak Ahead of Key US Data
MT
JCR Pharmaceuticals' Partner Takeda to Scrap Gene Therapy Collaboration
MT
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. 4552 Stock
  4. News JCR Pharmaceuticals Co., Ltd.